Nirvan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-06-2024
- Paid Up Capital ₹ 0.80 Cr
as on 20-06-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 70.26 Cr
as on 20-06-2024
- Satisfied Charges ₹ 41.49 Cr
as on 20-06-2024
- Revenue -4.04%
(FY 2021)
- Profit 5.37%
(FY 2021)
- Ebitda -82.68%
(FY 2021)
- Net Worth -201.57%
(FY 2021)
- Total Assets -4.69%
(FY 2021)
About Nirvan Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.80 Cr.
The company currently has active open charges totaling ₹70.26 Cr. The company has closed loans amounting to ₹41.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harish Kondapally, Sunil Yadav, Dharmvir Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U33112DL1996PTC076859
- Company No.
076859
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nirvan Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Kondapally  | Director | Current | |
| Sunil Yadav | Director | 06-Nov-2006 | Current |
| Dharmvir Singh | Director | 26-Aug-1996 | Current |
| Geeta Yadav | Director | 26-Dec-2023 | Current |
Financial Performance and Corporate Structure Insights of Nirvan Pharmaceuticals.
Nirvan Pharmaceuticals Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.04% decrease. The company also saw a slight improvement in profitability, with a 5.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 201.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirvan Pharmaceuticals?
In 2021, Nirvan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sheba Wheels Pvt Ltd
Active
48 years 2 months Harish Kondapally, Sunil Yadav and 1 more are mutual person
Nirvan International E-Services Private Limited
Active 22 years 7 months Harish Kondapally, Sunil Yadav and 1 more are mutual person
Nirvan Agro Packaging Private Limited
Active 50 years 5 months Sunil Yadav and Dharmvir Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Feb 2018 | ₹19.36 Cr | Open |
Bajaj Finance Limited Creation Date: 02 Jul 2015 | ₹10.00 Cr | Open |
Bajaj Finance Limited Creation Date: 31 Dec 2014 | ₹18.00 Cr | Open |
How Many Employees Work at Nirvan Pharmaceuticals?
Unlock and access historical data on people associated with Nirvan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirvan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirvan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
